References
- AgustiACalverleyPMCelliBCharacterisation of COPD heterogeneity in the ECLIPSE cohortRespir Res20101112220831787
- VogelmeierCFCrinerGJMartinezFJGlobal Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive SummaryAm J Respir Crit Care Med2017195555758228128970
- GroenewegenKHScholsAMWoutersEFMortality and mortality-related factors after hospitalization for acute exacerbation of COPDChest2003124245946712907529
- SeemungalTAHurstJRWedzichaJAExacerbation rate, health status and mortality in COPD – a review of potential interventionsInt J Chron Obstruct Pulmon Dis2009420322319554195
- SpencerSCalverleyPMBurgePSJonesPWImpact of preventing exacerbations on deterioration of health status in COPDEur Respir J200423569870215176682
- CelliBRThomasNEAndersonJAEffect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH studyAm J Respir Crit Care Med2008178433233818511702
- MakrisDMoschandreasJDamianakiAExacerbations and lung function decline in COPD: new insights in current and ex-smokersRespir Med200710161305131217112715
- DonaldsonGCSeemungalTABhowmikAWedzichaJARelationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary diseaseThorax2002571084785212324669
- Soler-CataluñaJJMartínez-GarcíaMARomán SánchezPSevere acute exacerbations and mortality in patients with chronic obstructive pulmonary diseaseThorax2005601192593116055622
- ZhouAZhouZZhaoYChenPThe recent advances of phenotypes in acute exacerbations of COPDInt J Chron Obstruct Pulmon Dis2017121009101828392685
- Lopez-CamposJLAgustíAHeterogeneity of chronic obstructive pulmonary disease exacerbations: a two-axes classification proposalLancet Respir Med20153972973426165134
- CalverleyPMAnzuetoARDusserDTreatment of exacerbations as a predictor of subsequent outcomes in patients with COPDInt J Chron Obstruct Pulmon Dis2018131297130829719385
- RabeKFHurdSAnzuetoAGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summaryAm J Respir Crit Care Med2007176653255517507545
- GrouseLNew studies address urgent need for early COPD diagnosisJ Thorac Dis201241192122295163
- LutchmedialSMCreedWGMooreAJHow common is airflow limitation in patients with emphysema on CT scan of the chest?Chest2015148117618425539080
- SeemungalTADonaldsonGCBhowmikAJeffriesDJWedzichaJATime course and recovery of exacerbations in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med200016151608161310806163
- Global Initiative for Chronic Obstructive Lung Disease (GOLD)Globalstrategy for the diagnosis, management, and prevention of chronicobstructive pulmonary disease (Update 2011) Available from: http://goldcopd.org/
- BestallJCPaulEAGarrodRGarnhamRJonesPWWedzichaJAUsefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary diseaseThorax199954758158610377201
- JonesPWHardingGBerryPDevelopment and first validation of the COPD Assessment TestEur Respir J200934364865419720809
- ZhouZZhouAZhaoYDuanJChenPA comparison of the assessment of health status between CCQ and CAT in a Chinese COPD clinical population: a cross-sectional analysisInt J Chron Obstruct Pulmon Dis2018131675168229872285
- TsiligianniIGvan der MolenTMoraitakiDAssessing health status in COPD. A head-to-head comparison between the COPD assessment test (CAT) and the clinical COPD questionnaire (CCQ)BMC Pulm Med2012122022607459
- MiravitllesMGarcía-SidroPFernández-NistalACourse of COPD assessment test (CAT) and clinical COPD questionnaire (CCQ) scores during recovery from exacerbations of chronic obstructive pulmonary diseaseHealth Qual Life Outcomes20131114723987232
- ChettaAOlivieriDThe COPD Assessment Test in the evaluation of chronic obstructive pulmonary disease exacerbationsExpert Rev Respir Med20126437337522971062
- MackayAJDonaldsonGCPatelARUsefulness of the Chronic Obstructive Pulmonary Disease Assessment Test to evaluate severity of COPD exacerbationsAm J Respir Crit Care Med2012185111218122422281834
- AgustíASolerJJMolinaJIs the CAT questionnaire sensitive to changes in health status in patients with severe COPD exacerbations?COPD20129549249822958111
- Folch AyoraAMacia-SolerLOrts-CortésMIHernándezCSeijas-BabotNComparative analysis of the psychometric parameters of two quality-of-life questionnaires, the SGRQ and CAT, in the assessment of patients with COPD exacerbations during hospitalization: a multicenter studyChron Respir Dis2018 479972318761645:147997231876164
- KardosPMokrosISauerRVogelmeierCFHealth status in patients with COPD treated with roflumilast: two large noninterventional real-life studies: DINO and DACOTAInt J Chron Obstruct Pulmon Dis2018131455146829765213
- Feliz-RodriguezDZudaireSCarpioCEvolution of the COPD Assessment Test score during chronic obstructive pulmonary disease exacerbations: determinants and prognostic valueCan Respir J2013205e92e9724093119
- TuYHZhangYFeiGHUtility of the CAT in the therapy assessment of COPD exacerbations in ChinaBMC Pulm Med2014144224618290
- PapaioannouMPitsiouGManikaKCOPD assessment test: a simple tool to evaluate disease severity and response to treatmentCOPD201411548949524766370
- JonesPWHardingGWiklundITests of the responsiveness of the COPD assessment test following acute exacerbation and pulmonary rehabilitationChest2012142113414022281796
- HuangWCWuMFChenHCHsuJYTOLD Group, MfW, Group TFeatures of COPD patients by comparing CAT with mMRC: a retrospective, cross-sectional studyNPJ Prim Care Respir Med2015251506326538368
- AntusBBartaIHorvathICsiszerERelationship between exhaled nitric oxide and treatment response in COPD patients with exacerbationsRespirology201015347247720210889
- MargaySMFarhatSKaurSTeliHATo study the efficacy and safety of doxophylline and theophylline in bronchial asthmaJ Clin Diagn Res201594FC05FC08
- DecramerMDekhuijzenPNTroostersTThe Bronchitis Randomized On NAC Cost-Utility Study (BRONCUS): hypothesis and design. BRONCUS-trial CommitteeEur Respir J200117332933611405507
- DaiMYQiaoJPXuYHFeiGHRespiratory infectious phenotypes in acute exacerbation of COPD: an aid to length of stay and COPD Assessment TestInt J Chron Obstruct Pulmon Dis2015102257226326527871
- GiffordSZambonJPOrlandoGRecycling organs – growing tailor-made replacement kidneysRegen Med201510891391526542737
- GhodsAAKhabiriRRaeisdanaNPredictors of inappropriate hospital stay: experience from IranGlob J Health Sci201473828925948427
- García-SidroPNavalEMartinez RiveraCThe CAT (COPD Assessment Test) questionnaire as a predictor of the evolution of severe COPD exacerbationsRespir Med2015109121546155226542727
- KonSSCanavanJLJonesSEMinimum clinically important difference for the COPD Assessment Test: a prospective analysisLancet Respir Med20142319520324621681
- SmidDEFranssenFMHouben-WilkeSResponsiveness and MCID estimates for CAT, CCQ, and HADS in patients with COPD undergoing pulmonary rehabilitation: a prospective analysisJ Am Med Dir Assoc2017181535827624705
- AlmaHde JongCJelusicDHealth status instruments for patients with COPD in pulmonary rehabilitation: defining a minimal clinically important differenceNPJ Prim Care Respir Med2016261604127597571